APG777A Long-term Safety and Efficacy Study Evaluating APG777 in Atopic Dermatitis

Sponsor:

Apogee Therapeutics, Inc.

Code:

NCT07003425

Conditions

Atopic Dermatitis

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

APG777

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2026-08-25. This information was provided to ClinicalTrials.gov by Apogee Therapeutics, Inc. on 2026-08-21.